PDF 77 KB
Summary of hepatitis a, b, c, d and e and links for specific information on each of the types
Further information is available on the Hepatitis A — including symptoms, treatment and prevention web page
Faecal-oral
Faeces containing the virus are transferred from the infected person to another person’s mouth.
Most infections in Australia are associated with:
Symptoms occur in less than 10% of young children and 40 to 70% of adults who become infected.
Does not occur in hepatitis A infection
Yes
Further information is available on the Hepatitis B — including symptoms, treatment and prevention web page
Blood-to-blood and sexual contact
Most infections in Australia are associated with:
Symptoms occur in up to 50% of adults in the period 2 to 3 months after infection.
Develops in:
Yes
Further information is available on the Hepatitis C — including symptoms, treatment and prevention web page
Blood-to-blood contact
Most infections in Australia are associated with:
15 to 25% of people will develop symptoms which are usually mild and may include jaundice.
50 to 80% of people remain chronically infected.
25% of this group will develop scarring of the liver (cirrhosis) and some will develop liver cancer
No
Further information is available on the Hepatitis D — including symptoms, treatment and prevention web page
Blood-to-blood contact
Most infections in Australia are associated with:
In co-infection, acute hepatitis B and D occur simultaneously. Super infection occurs in people already infected with hepatitis B.
More likely after super infection
Yes with hepatitis B vaccine
Further information is available on the Hepatitis E — including symptoms, treatment and prevention web page
Faecal-oral
Faeces containing the virus are transferred to another person’s mouth.
Most infections in Australia are associated with travel to countries where hepatitis E is endemic (always present).
Less commonly, infection can be passed from a pregnant woman to her fetus, or through infected blood transfusion.
Symptoms are rare in young children. Disease is usually self-limiting with recovery but can be serious, particularly in pregnant women.
Does not occur in hepatitis E infection
No
Antibiotics, vaccination or immunoglobulin (a solution containing human antibodies that is made from blood products) may be offered to contacts after exposure to some infectious diseases. A contact is any person who has been close enough to an infected person to be at risk of having acquired the infection from that person. PEP may prevent the development of the infection during the incubation period, make the infection less severe if it does develop, or reduce the risk of the infection being passed on to other people.
An acute infection occurs when symptoms show up soon after the person is infected (usually within days or weeks). Symptoms may include abdominal discomfort, nausea, fever, fatigue, sometimes followed by jaundice (yellow skin and eyes)
There may be no symptoms but the person remains infected. Chronic infection may lead to cirrhosis (scarring of the liver), liver failure or liver cancer in some people